Oregon Department of Consumer and Business Services, Insurance Regulation

Rule Rule 836-200-0515
Threshold for Reporting Drug Price Increase


(1) No later than July 1, 2019, a reporting manufacturer must report the information described in OAR 836-200-0530 (Form and Manner Requirements for Drug Pricing Reporting) (2) to the department regarding each prescription drug for which:
(a) The price at any point in 2018 was $100 or more for a one-month supply or for a course of treatment lasting less than one month; and
(b) There was a net yearly increase of 10 percent or more in the price of the prescription drug described in paragraph (a) of this subsection during 2018.
(2) Beginning March 15, 2020, no later than March 15 annually, a reporting manufacturer must report to the department the information described in OAR 836-200-0530 (Form and Manner Requirements for Drug Pricing Reporting) (2) regarding each prescription drug for which:
(a) The price at any point during the previous year was $100 or more for a one-month supply or for a course of treatment lasting less than one month; and
(b) There was a net yearly increase of 10 percent or more in the price of the prescription drug described in paragraph (a) of this subsection over the course of the previous calendar year.
Source

Last accessed
Jun. 8, 2021